CELEBRATE
Phase 1/2 Unknown
78 enrolled
ACTME
Phase 1/2 Unknown
34 enrolled
PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
Phase 1/2 Unknown
50 enrolled
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Phase 1/2 Unknown
172 enrolled
Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
Phase 1/2 Unknown
22 enrolled
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Phase 1/2 Unknown
314 enrolled
ICEMELT
Phase 1/2 Unknown
200 enrolled
Nivo-TIL
Phase 1/2 Unknown
11 enrolled
A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma
Phase 1/2 Unknown
96 enrolled
CHARLI
Phase 1/2 Unknown
72 enrolled
NeoPepVac
Phase 1/2 Unknown
12 enrolled
Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors
Phase 1/2 Unknown
39 enrolled
A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC
Phase 1/2 Unknown
42 enrolled
COMBI-R2
Phase 1/2 Unknown
63 enrolled
SONIMEL01
Phase 1/2 Unknown
21 enrolled
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Phase 1/2 Unknown
73 enrolled
TCR
Phase 1/2 Unknown
12 enrolled
A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
Phase 1/2 Unknown
63 enrolled
In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma
Phase 1/2 Unknown
30 enrolled
OPTIMUM
Phase 1/2 Unknown
40 enrolled
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
Phase 1/2 Unknown
60 enrolled
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Phase 1/2 Unknown
50 enrolled
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1/2 Unknown
30 enrolled
Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Phase 1/2 Unknown
54 enrolled
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
Phase 1/2 Unknown
36 enrolled
Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
Phase 1/2 Unknown
Vaccine Therapy in Treating Patients With Stage IV Melanoma
Phase 1/2 Unknown
30 enrolled
Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes
Phase 1/2 Unknown
22 enrolled
THERAVAC
Phase 1/2 Unknown
23 enrolled
Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)
Phase 1/2 Unknown
15 enrolled
Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
Phase 1/2 Unknown
58 enrolled
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer
Phase 1/2 Unknown
70 enrolled
Pain Relief - Tramadol Versus Ibuprofen
Phase 1/2 Unknown
40 enrolled